Data Science in the News

Accelerating the path to precision medicine

LLNL joined the Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) consortium in 2018. The national, multiyear, multidisciplinary effort, led by the University of California at San Francisco in collaboration with Lawrence Berkeley and Argonne national laboratories and other leading research organizations and universities, combines neuroimaging, blood-based...

Machine learning model finds COVID-19 risks for cancer patients

A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

LLNL team models COVID-19 disease progression and identifies risk factors

An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...

COVID-19 R&D: Computing responds to pandemic

When the COVID-19 pandemic began, the Laboratory immediately started seeking solutions to the myriad challenges posed by the global crisis. The Computing Directorate jumped right in with research and development activities that combine molecular screening to inform antiviral drug experimentation; a generative molecular design software platform to optimize properties of antiviral drugs; an...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Tackling the COVID-19 pandemic

To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

Inaugural industry forum inspires ML community

LLNL held its first-ever Machine Learning for Industry Forum (ML4I) on August 10–12. Co-hosted by the Lab’s High-Performance Computing Innovation Center (HPCIC) and Data Science Institute (DSI), the virtual event brought together more than 500 enrollees from the Department of Energy (DOE) complex, commercial companies, professional societies, and academia. Industry sponsors included...

Visualization software stands the test of time

In the decades since LLNL’s founding, the technology used in pursuit of the Laboratory’s national security mission has changed over time. For example, studying scientific phenomena and predicting their behaviors require increasingly robust, high-resolution simulations. These crucial tasks compound the demands on high-performance computing hardware and software, which must continually be...

60 years of cancer research

From studying radioactive isotope effects to better understanding cancer metastasis, the Laboratory’s relationship with cancer research endures some 60 years after it began, with historical precedent underpinning exciting new research areas. In one Cancer Moonshot project, research includes a close synergy between experiments and computation, allowing scientists to get a better picture of the...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

Laser-driven ion acceleration with deep learning

While advances in machine learning over the past decade have made significant impacts in applications such as image classification, natural language processing and pattern recognition, scientific endeavors have only just begun to leverage this technology. This is most notable in processing large quantities of data from experiments. Research conducted at LLNL is the first to apply neural...

The data-driven future of extreme physics

By applying modern machine learning and data science methods to “extreme” plasma physics, researchers can gain insight into our universe and find clues about creating a limitless amount of energy. In a recent perspective published in Nature, LLNL scientists and international collaborators outline key challenges and future directions in using machine learning and other data-driven techniques...

Conference papers highlight importance of data security to machine learning

The 2021 Conference on Computer Vision and Pattern Recognition, the premier conference of its kind, will feature two papers co-authored by an LLNL researcher targeted at improving the understanding of robust machine learning models. Both papers include contributions from LLNL computer scientist Bhavya Kailkhura and examine the importance of data in building models, part of a Lab effort to...

COVID-19 HPC Consortium reflects on past year

COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Winter hackathon highlights data science talks and tutorial

The Data Science Institute (DSI) sponsored LLNL’s 27th hackathon on February 11–12. Held four times a year, these seasonal events bring the computing community together for a 24-hour period where anything goes: Participants can focus on special projects, learn new programming languages, develop skills, dig into challenging tasks, and more. The winter hackathon was the DSI’s second such...

Lawrence Livermore computer scientist heads award-winning computer vision research

The 2021 IEEE Winter Conference on Applications of Computer Vision (WACV 2021) on Wednesday announced that a paper co-authored by LLNL computer scientist Rushil Anirudh received the conference’s Best Paper Honorable Mention award based on its potential impact to the field. The paper, titled "Generative Patch Priors for Practical Compressive Image Recovery,” introduces a new kind of prior—a...

Model for COVID-19 drug discovery a Gordon Bell finalist

A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

DOE announces five new energy projects at LLNL

The DOE today announced two rounds of awards for the High Performance Computing for Energy Innovation Program HPC4EI), including five projects at LLNL. HPC4EI connects industry with the computational resources and expertise of the DOE national laboratories to solve challenges in manufacturing, accelerate discovery and adoption of new materials and improve energy efficiency. The awards were...

From intern to mentor, Nisha Mulakken builds a career in bioinformatics

The COVID-19 pandemic has sparked a wave of new research and development at the Lab, and Nisha Mulakken is very busy. The biostatistician has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated...

Advancing healthcare with data science (VIDEO)

This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...